citric acid, anhydrous has been researched along with Metabolic Diseases in 21 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " TPM dosage correlated inversely with urinary citrate excretion (Pearson correlation coefficient = -0." | 5.37 | Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate. ( Kaplon, DM; Nakada, SY; Penniston, KL, 2011) |
| "This study revealed a metabolic tendency to hypercalciuria in calcium oxalate stone patients, predominantly in those with recurrent calcium oxalate urolithiasis." | 3.83 | Metabolic assessment of recurrent and first renal calcium oxalate stone formers. ( Çakıroğlu, B; Eyyupoğlu, E; Hazar, AI; Nuhoğlu, B; Uyanik, BS, 2016) |
| " In our study, calcium and uric acid abnormalities were the most common, and vesicoureteral reflux seemed to be the most common urological abnormality which led to urinary stasis and calculus formation." | 3.76 | Metabolic factors associated with urinary calculi in children. ( Alamdaran, SA; Naseri, M; Varasteh, AR, 2010) |
| "Patients with urolithiasis have a lower bone mineral density (BMD) than those without stones, suggesting a potential correlation between calcium stone formation and bone resorption disorders, including osteopenia and osteoporosis." | 1.56 | Low bone mineral density is a potential risk factor for symptom onset and related with hypocitraturia in urolithiasis patients: a single-center retrospective cohort study. ( Ando, R; Hamamoto, S; Kato, T; Okada, A; Sugino, T; Taguchi, K; Tanaka, Y; Tozawa, K; Unno, R; Yasui, T, 2020) |
| " TPM dosage correlated inversely with urinary citrate excretion (Pearson correlation coefficient = -0." | 1.37 | Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate. ( Kaplon, DM; Nakada, SY; Penniston, KL, 2011) |
| "Hypercalciuria was detected in 9/47, hyperoxaluria in 5/39, hypocitraturia in 4/31, and cystinuria in 2/50 infants." | 1.36 | Urolithiasis in the first year of life. ( Akbas, H; Akman, S; Alimoglu, E; Baysal, YE; Güven, AG; Kabaalioglu, A; Koyun, M, 2010) |
| "Urolithiasis is one of the commonest problems in pediatric nephrology." | 1.36 | Clinical manifestations and etiology of renal stones in children less than 14 years age. ( Heidari, A; Sepahi, MA; Shajari, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, MJ | 2 |
| Khan, SA | 2 |
| Kumar, B | 2 |
| Chawla, P | 2 |
| Bhatia, R | 2 |
| Singh, K | 2 |
| Taguchi, K | 1 |
| Hamamoto, S | 1 |
| Okada, A | 1 |
| Tanaka, Y | 1 |
| Sugino, T | 1 |
| Unno, R | 1 |
| Kato, T | 1 |
| Ando, R | 1 |
| Tozawa, K | 1 |
| Yasui, T | 1 |
| Huynh, LM | 1 |
| Dianatnejad, S | 1 |
| Tofani, S | 1 |
| Carrillo Ceja, R | 1 |
| Liang, K | 1 |
| Tapiero, S | 1 |
| Jiang, P | 1 |
| Youssef, RF | 1 |
| Mosaoa, R | 1 |
| Kasprzyk-Pawelec, A | 1 |
| Fernandez, HR | 1 |
| Avantaggiati, ML | 1 |
| Willmes, DM | 1 |
| Kurzbach, A | 1 |
| Henke, C | 1 |
| Schumann, T | 1 |
| Zahn, G | 1 |
| Heifetz, A | 1 |
| Jordan, J | 1 |
| Helfand, SL | 1 |
| Birkenfeld, AL | 1 |
| Khadzhynov, D | 1 |
| Schelter, C | 1 |
| Lieker, I | 1 |
| Mika, A | 1 |
| Staeck, O | 1 |
| Neumayer, HH | 1 |
| Peters, H | 1 |
| Slowinski, T | 1 |
| Çakıroğlu, B | 1 |
| Eyyupoğlu, E | 1 |
| Hazar, AI | 1 |
| Uyanik, BS | 1 |
| Nuhoğlu, B | 1 |
| Kustov, AV | 1 |
| Moryganov, MA | 1 |
| Strel'nikov, AI | 1 |
| Zhuravleva, NI | 1 |
| Airapetyan, AO | 1 |
| Stoller, ML | 1 |
| Chi, T | 1 |
| Eisner, BH | 1 |
| Shami, G | 1 |
| Gentle, DL | 1 |
| Alpay, H | 1 |
| Ozen, A | 1 |
| Gokce, I | 1 |
| Biyikli, N | 1 |
| Güven, AG | 1 |
| Koyun, M | 1 |
| Baysal, YE | 1 |
| Akman, S | 1 |
| Alimoglu, E | 1 |
| Akbas, H | 1 |
| Kabaalioglu, A | 1 |
| Sepahi, MA | 1 |
| Heidari, A | 1 |
| Shajari, A | 1 |
| Naseri, M | 1 |
| Varasteh, AR | 1 |
| Alamdaran, SA | 1 |
| Kaplon, DM | 1 |
| Penniston, KL | 1 |
| Nakada, SY | 1 |
| NORDIO, S | 1 |
| DE PRA, M | 1 |
| KOMARKOVA, A | 1 |
| VITKOVA, E | 1 |
| PACOVSKY, V | 1 |
| VOSTAL, J | 1 |
| BLEHA, O | 1 |
| Kang, DE | 1 |
| Sur, RL | 1 |
| Haleblian, GE | 1 |
| Fitzsimons, NJ | 1 |
| Borawski, KM | 1 |
| Preminger, GM | 1 |
| Scott, WA | 1 |
| Campoy Martínez, P | 1 |
| Reina Ruiz, C | 1 |
| Salazar Murillo, R | 1 |
| Quintero Rodríguez, R | 1 |
| Espinosa Olmedo, FJ | 1 |
| García Pérez, M | 1 |
| Schelling, JR | 1 |
| Laminski, NA | 1 |
| Meyers, AM | 1 |
| Sonnekus, MI | 1 |
| Smyth, AE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Filters Useful Life, Metabolic Control, Electrolyte Profile and Acid-base Balance During Regional Anticoagulation With 4% Trisodium Citrate in Patients Undergoing CVVHDF: Effects of Increased Blood Flow[NCT05796661] | 27 participants (Anticipated) | Interventional | 2023-01-09 | Recruiting | |||
| Apple Cider Vinegar for the Prevention of Urinary Lithiasis (APUL)[NCT04073719] | 50 participants (Anticipated) | Interventional | 2019-09-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for citric acid, anhydrous and Metabolic Diseases
| Article | Year |
|---|---|
Role of sodium dependent SLC13 transporter inhibitors in various metabolic disorders.
Topics: Animals; Citrates; Citric Acid; Fatty Acids; Humans; Membrane Transport Proteins; Metabolic Diseases | 2023 |
Role of sodium dependent SLC13 transporter inhibitors in various metabolic disorders.
Topics: Animals; Citrates; Citric Acid; Fatty Acids; Humans; Membrane Transport Proteins; Metabolic Diseases | 2023 |
Role of sodium dependent SLC13 transporter inhibitors in various metabolic disorders.
Topics: Animals; Citrates; Citric Acid; Fatty Acids; Humans; Membrane Transport Proteins; Metabolic Diseases | 2023 |
Role of sodium dependent SLC13 transporter inhibitors in various metabolic disorders.
Topics: Animals; Citrates; Citric Acid; Fatty Acids; Humans; Membrane Transport Proteins; Metabolic Diseases | 2023 |
Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
Topics: Citric Acid; Female; Global Health; Humans; Hypercalciuria; Hyperoxaluria; Kidney Calculi; Male; Met | 2020 |
The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond.
Topics: Allosteric Site; Animals; Chromosomes, Human, Pair 22; Citrates; Citric Acid; Cytosol; Diabetes Mell | 2021 |
The longevity gene INDY (I'm Not Dead Yet) in metabolic control: Potential as pharmacological target.
Topics: Animals; Citric Acid; Dicarboxylic Acid Transporters; Humans; Longevity; Metabolic Diseases; Neurons | 2018 |
1 trial available for citric acid, anhydrous and Metabolic Diseases
| Article | Year |
|---|---|
Prevalence of hypocitraturia and hypopyrophosphaturia in recurrent calcium stone formers: as isolated defects or associated with other metabolic abnormalities.
Topics: Adolescent; Adult; Aged; Calcium; Citrates; Citric Acid; Diphosphates; Female; Humans; Kidney Calcul | 1990 |
16 other studies available for citric acid, anhydrous and Metabolic Diseases
| Article | Year |
|---|---|
Low bone mineral density is a potential risk factor for symptom onset and related with hypocitraturia in urolithiasis patients: a single-center retrospective cohort study.
Topics: Adult; Aged; Bone Diseases, Metabolic; Citric Acid; Cohort Studies; Correlation of Data; Female; Hum | 2020 |
Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.
Topics: Acute Kidney Injury; Aged; Anticoagulants; Calcium; Citrates; Citric Acid; Critical Illness; Female; | 2014 |
Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
Topics: Adult; Calcium; Calcium Oxalate; Citric Acid; Female; Follow-Up Studies; Humans; Hypercalciuria; Kid | 2016 |
[Quantitative mineralogical analyzes of kidney stones and diagnosing metabolic disorders in female patients with calcium oxalate urolithiasis].
Topics: Adult; Age Factors; Aged; Calcium Oxalate; Citric Acid; Durapatite; Female; Humans; Kidney Calculi; | 2016 |
Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Topics: Adult; Aged; Calcium Oxalate; Citric Acid; Dietary Supplements; Female; Humans; Kidney Calculi; Male | 2009 |
Clinical and metabolic features of urolithiasis and microlithiasis in children.
Topics: Calcium; Child; Child, Preschool; Citric Acid; Cystinuria; Female; Humans; Hypercalciuria; Hyperoxal | 2009 |
Urolithiasis in the first year of life.
Topics: Blood Chemical Analysis; Child, Preschool; Citric Acid; Cystinuria; Female; Humans; Hypercalciuria; | 2010 |
Clinical manifestations and etiology of renal stones in children less than 14 years age.
Topics: Adolescent; Child; Child, Preschool; Citric Acid; Cystinuria; Dysuria; Female; Fever; Genetic Predis | 2010 |
Metabolic factors associated with urinary calculi in children.
Topics: Adolescent; Calcium; Child; Child, Preschool; Citric Acid; Cystinuria; Female; Humans; Hypercalciuri | 2010 |
Patients with and without prior urolithiasis have hypocitraturia and incident kidney stones while on topiramate.
Topics: Anticonvulsants; Citric Acid; Female; Fructose; Humans; Kidney Calculi; Male; Metabolic Diseases; Re | 2011 |
[Renal clearance of citric acid in some diseases of calciophosphoric metabolism. A new form of rickets (with "citric renal diabetes")].
Topics: Citrates; Citric Acid; Diabetes Mellitus; Humans; Kidney Function Tests; Metabolic Diseases; Rickets | 1961 |
[Citric acid and metabolic diseases of the bone. I. Preliminary communication. Certain new finding on metabolic relation of citric acid to bones].
Topics: Bone and Bones; Citrates; Citric Acid; Metabolic Diseases | 1959 |
Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis.
Topics: Adult; Aged; Beverages; Citric Acid; Citrus; Female; Humans; Male; Metabolic Diseases; Middle Aged; | 2007 |
Asymptomatic hyperuricaemia and its early treatment.
Topics: Bicarbonates; Citrates; Citric Acid; Drug Combinations; Female; Humans; Male; Metabolic Diseases; So | 1980 |
[A metabolic study of urolithiasis. Specificity, sensitivity, efficacy and reproducibility].
Topics: Absorption; Adolescent; Adult; Aged; Calcium; Citrates; Citric Acid; Clinical Protocols; Creatinine; | 1995 |
Fatal hypermagnesemia.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Cathartics; Citric Acid; Fatal Outcome; Female; Humans | 2000 |